glp 1 dose conversion GLP-1 chart and safe switching guide How long do you have

Overview of modern GLP-1based medicines and type 2 diabetes GLP1RAs like exenatide, liraglutide, semaglutide, and tirzepatide are widely used for type 2 diabetes and obesity, offering significant benefits in glucose control, weight loss, and cardiovascular health

The ACHIEVE-4 trialthe biggest and longest phase 3 study of Foundayo to datefollowed over 2,700 people across 15 countries for 104 weeks

Diabetic patients treated with semaglutide (Ozempic) showed substantial weight loss with some patients losing more than 10% of their weight

The majority of the available GLP1RAs are not recommended for use in patients with endstage renal disease (estimated glomerular filtration rate [eGFR] 1 month), then the dose of the current GLP1RA should be considered

10.1038/s41591-021-01418-2 155 SlootY

T lymphocyte function is modulated through inhibition of pro-inflammatory Th17 differentiation and promotion of regulatory T cell (Treg) expansion via STAT5-dependent mechanisms [42,43]